learn quest call
price
result underscor lab share gain thesi cost-cut
benefit materi ahead expect rais price
target catalyst lh earn market open
share gain expens region lab thesi play underli
organ growth adjust basi point headwind
low margin capit contract repres bp sequenti gain
underli organ growth primari sourc growth
pickup unit horizon volum quest see share gain across
payer ahead intern expect increment growth mostli
region player lesser extent labcorp report
look ahead believ organ volum growth continu improv
sequenti remaind year continu gain
share region lab benefit prefer lab network
start august unit make difficult provid go
network provid refer member out-of-network lab
subject on-line approv process think administr
hurdl like de-incentiv provid util region lab
steer volum pln simpli way avoid extra paperwork overal
uptak pln depend physician patient incent put
place continu look color
incent year progress move align clinic lab
patholog servic reimburs rate hospital-bas labs/patholog
group independ lab anoth step right direct expect
take longer time play hospit may still opt use exist
lab infrastructur even lower level econom compens
cost-cut initi make mark quest adjust gross margin y/i
declin bp lower bp y/i declin adjust
gross margin underscor effort lean cost
 distribut unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
base consensu methodolog
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
structur yield result even period price headwind expect
save ramp cours year provid cushion guidanc
support long-term earn acceler context quest goal reduc
billion cost base cog sg million annual
impli guidanc like conserv manag use beat
ant opt reaffirm guidanc impli ep
lower ms/con call
manag emphas chose factor conservat light last
year guidanc revis suggest guidanc like view floor
rais ep estim reflect beat model revenu
million y/i in-lin unchang guidanc million
million y/i model ep y/i vs
y/i previous in-lin guidanc y/i ep
estim y/i remain unchang
updat price target updat dcf-base price
target reflect updat wacc vs previous beta vs
previous risk free rate vs previous equiti risk
premium vs previous near- medium-term revenu
growth expect remain unchang pt impli
forward price-to-earnings multipl bull case
bear case
made corrections/addit exhibit exhibit section articl
correspond text articl origin publish juli
pm gmt republish juli price data
disclosur reflect origin public date receiv electron copi
origin version public pleas send email
public titl
base case dcf includ termin growth wacc
impli price-to-earnings bull case ep
impli price-to-earnings bull case ep
top-line growth sustain medium-term growth
share gain come faster-than-expect in-network access
prefer network uptak cost cut initi drive higher-than-expect
save termin growth rate
impli price-to-earnings base case ep
impli price-to-earnings base case ep
top-line growth sustain medium-term
growth contract drive major bp
underli organ volum growth partial off-set bp price
headwind go in-network termin growth rate
impli price-to-earnings bear case ep
impli price-to-earnings bear case ep
top-line declin medium-term growth similarli
challeng quest struggl see manag care plan share gain
activ slow termin growth rate
largest nation
lab market share physician lab
unit decis open lab contract
establish long-term strateg
partnership two nation lab quest
diagnost labcorp set stage
ration price provid quest
opportun gain market share
capit deploy form tuck-in
cost cut program invigor
molecular diagnost supplement
volum growth move in-network
bcbsnj well
risk achiev price
volum growth share gain meet
save program magnitud come
expect
neg pama impact commerci
exhibit quest diagnost slower y/i gross margin contract
compani data estim
